-
1
-
-
0000380094
-
Inhibition by puromycin of amino acid incorporation into protein
-
10.1073/pnas.45.12.1721 1:CAS:528:DyaF3cXos1KrtQ%3D%3D
-
Yarmolinsky MB, Haba GL (1959) Inhibition by puromycin of amino acid incorporation into protein. Proc Natl Acad Sci (USA) 45(12):1721-1729
-
(1959)
Proc Natl Acad Sci (USA)
, vol.45
, Issue.12
, pp. 1721-1729
-
-
Yarmolinsky, M.B.1
Haba, G.L.2
-
2
-
-
0000603264
-
Puromycin inhibition of protein synthesis: Incorporation of puromycin into peptide chains
-
10.1073/pnas.51.4.585 1:CAS:528:DyaF2cXktFagurw%3D
-
Nathans D (1964) Puromycin inhibition of protein synthesis: incorporation of puromycin into peptide chains. Proc Natl Acad Sci (USA) 51:585-592
-
(1964)
Proc Natl Acad Sci (USA)
, vol.51
, pp. 585-592
-
-
Nathans, D.1
-
3
-
-
0034159931
-
Specific bonding of puromycin to full-length protein at the C-terminus
-
10666460 10.1093/nar/28.5.1176 1:CAS:528:DC%2BD3cXitVaku7g%3D
-
Miyamoto-Sato E, Nemoto N, Kobayashi K et al (2000) Specific bonding of puromycin to full-length protein at the C-terminus. Nucleic Acids Res 28(5):1176-1182
-
(2000)
Nucleic Acids Res
, vol.28
, Issue.5
, pp. 1176-1182
-
-
Miyamoto-Sato, E.1
Nemoto, N.2
Kobayashi, K.3
-
4
-
-
0036077695
-
Puromycin oligonucleotides reveal steric restrictions for ribosome entry and multiple modes of translation inhibition
-
10.1017/S1355838202022069
-
Starck SR, Roberts RW (2002) Puromycin oligonucleotides reveal steric restrictions for ribosome entry and multiple modes of translation inhibition. RNA 8:15
-
(2002)
RNA
, vol.8
, pp. 15
-
-
Starck, S.R.1
Roberts, R.W.2
-
5
-
-
77956183469
-
PET radiopharmaceuticals in radiation treatment planning - Synthesis and biological characteristics
-
20724013 10.1016/j.radonc.2010.07.022
-
Haubner R (2010) PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics. Radiother Oncol 96(3):280-287
-
(2010)
Radiother Oncol
, vol.96
, Issue.3
, pp. 280-287
-
-
Haubner, R.1
-
6
-
-
0032733647
-
Fluorescence labeling of the C-terminus of proteins with a puromycin analogue in cell-free translation systems
-
10580088 10.1016/S0014-5793(99)01474-X 1:CAS:528:DyaK1MXnsVKlsr0%3D
-
Nemoto N, Miyamoto-Sato E, Yanagawa H (1999) Fluorescence labeling of the C-terminus of proteins with a puromycin analogue in cell-free translation systems. FEBS Lett 462(1-2):43-46
-
(1999)
FEBS Lett
, vol.462
, Issue.1-2
, pp. 43-46
-
-
Nemoto, N.1
Miyamoto-Sato, E.2
Yanagawa, H.3
-
7
-
-
3142674310
-
-
The Netherlands: Kluwer Academic Publishers
-
Rösch F, Knapp F (eds) (2004) Radionuclide generators. The Netherlands: Kluwer Academic Publishers. vol. 4, p 81-118
-
(2004)
Radionuclide Generators
, vol.4
, pp. 81-118
-
-
Rösch F, K.1
-
8
-
-
77956106803
-
A 44Ti/44Sc radionuclide generator for potential application of 44Sc-based PET-radiopharmaceuticals
-
10.1524/ract.2010.1701 1:CAS:528:DC%2BC3cXjvVOjtbo%3D
-
Filosofov DV, Loktionova NS, Rösch F (2010) A 44Ti/44Sc radionuclide generator for potential application of 44Sc-based PET-radiopharmaceuticals. Radiochim Acta 98(3):149-156
-
(2010)
Radiochim Acta
, vol.98
, Issue.3
, pp. 149-156
-
-
Filosofov, D.V.1
Loktionova, N.S.2
Rösch, F.3
-
9
-
-
78650761978
-
Post-elution processing of 44Ti/44Sc generator-derived 44Sc for clinical application
-
20434351 10.1016/j.apradiso.2010.04.003
-
Pruszyński M, Loktionova NS, Filosofov DV et al (2010) Post-elution processing of 44Ti/44Sc generator-derived 44Sc for clinical application. Appl Radiat Isot 68(9):1636-1641
-
(2010)
Appl Radiat Isot
, vol.68
, Issue.9
, pp. 1636-1641
-
-
Pruszyński, M.1
Loktionova, N.S.2
Filosofov, D.V.3
-
10
-
-
33644995190
-
Molecular imaging: What can be used today
-
SPEC NO A 16361133 10.1102/1470-7330.2005.0023
-
Jager PL, de Korte MA, Lub-de Hooge MN et al (2005) Molecular imaging: what can be used today. Cancer Imaging 5(Spec No A):S27-S32
-
(2005)
Cancer Imaging
, vol.5
-
-
Jager, P.L.1
De Korte, M.A.2
Lub-De Hooge, M.N.3
-
11
-
-
0027958185
-
Gallium-67/gallium-68-[DFO]-octreotide - A potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: Synthesis and radiolabeling in vitro and preliminary in vivo studies
-
8295005 1:CAS:528:DyaK2cXlvF2ksrs%3D
-
Smith-Jones PM, Stolz B, Bruns C et al (1994) Gallium-67/gallium-68-[DFO] -octreotide - a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J Nucl Med 35(2):317-325
-
(1994)
J Nucl Med
, vol.35
, Issue.2
, pp. 317-325
-
-
Smith-Jones, P.M.1
Stolz, B.2
Bruns, C.3
-
12
-
-
20344374435
-
Radiolabeled small-molecule ligands for prostate-specific membrane antigen: In vivo imaging in experimental models of prostate cancer
-
15930336 10.1158/1078-0432.CCR-04-2690 1:CAS:528:DC%2BD2MXks1Gksr0%3D
-
Foss CA, Mease RC, Fan H et al (2005) Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin Cancer Res 11(11):4022-4028
-
(2005)
Clin Cancer Res
, vol.11
, Issue.11
, pp. 4022-4028
-
-
Foss, C.A.1
Mease, R.C.2
Fan, H.3
-
13
-
-
0001457849
-
Action of puromycin in polyadenylic acid-directed polylysine synthesis
-
10.1016/S0022-2836(65)80130-9 1:CAS:528:DyaF28XltVai
-
Smith J, Traut R, Blackburn G et al (1965) Action of puromycin in polyadenylic acid-directed polylysine synthesis. J Mol Biol 13:617-628
-
(1965)
J Mol Biol
, vol.13
, pp. 617-628
-
-
Smith, J.1
Traut, R.2
Blackburn, G.3
-
14
-
-
3943086375
-
68Ga-labelled DOTA-derivatised peptide ligands
-
15029459 10.1007/s00259-004-1486-0 1:CAS:528:DC%2BD2cXmtFWks7o%3D
-
Meyer GJ, Macke H, Schuhmacher J et al (2004) 68Ga-labelled DOTA-derivatised peptide ligands. Eur J Nucl Med Mol Imaging 31(8):1097-1104
-
(2004)
Eur J Nucl Med Mol Imaging
, vol.31
, Issue.8
, pp. 1097-1104
-
-
Meyer, G.J.1
MacKe, H.2
Schuhmacher, J.3
-
15
-
-
1542504579
-
68Ga-labeled oligonucleotides for in vivo imaging with PET
-
14960659 1:CAS:528:DC%2BD2cXitVCrtbk%3D
-
Roivainen A, Tolvanen T, Salomaki S et al (2004) 68Ga-labeled oligonucleotides for in vivo imaging with PET. J Nucl Med 45(2):347-355
-
(2004)
J Nucl Med
, vol.45
, Issue.2
, pp. 347-355
-
-
Roivainen, A.1
Tolvanen, T.2
Salomaki, S.3
|